Teva Pharmaceutical Industries Ltd (TEVA) stock
TEVANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30127% above fair value
$42.57−1.93 (-4.34%)
Close on Nov 16, 2026Market cap $49.61BP/E 71.0Yield –
Teva Pharmaceutical Industries market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Teva Pharmaceutical Industries's market cap was $49.61B on Nov 10, 2026, against $31.04B a year earlier. Over the last 5 years it ranged from $8.02B to $49.61B, with a median of $17.54B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 10, 2026 | $49.61B | +37.7% |
| 2025 | Dec 31, 2025 | $36.03B | +45.1% |
| 2024 | Dec 31, 2024 | $24.84B | +112.3% |
| 2023 | Dec 29, 2023 | $11.70B | +15.7% |
| 2022 | Dec 30, 2022 | $10.12B | +14.3% |
| 2021 | Dec 31, 2021 | $8.85B | -16.3% |
| 2020 | Dec 31, 2020 | $10.57B | +0.4% |
| 2019 | Dec 31, 2019 | $10.53B | -32.9% |
| 2018 | Dec 31, 2018 | $15.70B | -49.2% |
| 2017 | Jan 31, 2017 | $30.92B | -7.8% |
| 2016 | Dec 30, 2016 | $33.53B | -40.6% |
| 2015 | Dec 31, 2015 | $56.47B | +14.9% |
| 2014 | Dec 31, 2014 | $49.13B | +43.4% |
| 2013 | Dec 31, 2013 | $34.25B | +4.6% |
| 2012 | Dec 31, 2012 | $32.75B | -10.1% |
| 2011 | Dec 30, 2011 | $36.41B | -25.4% |
| 2010 | Dec 31, 2010 | $48.79B | -5.5% |
| 2009 | Dec 31, 2009 | $51.63B | – |
See a number that looks wrong?